Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Chemotherapy and Autologous Stem Cell Transplant or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma - Randomized Phase III Trial

NCT02531841 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.

NCT NCT02531841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02531841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Chemotherapy and Autologous Stem Cell Transplant or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma - Randomized Phase III Trial
Lead sponsor
University Hospital Freiburg
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2014
Completion date
December 31, 2019
Enrollment
250 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell-lymphoma